Nitric oxide-releasing nanoparticles accelerate wound healing in NOD-SCID mice.

UNLABELLED Wound healing is a complex process, coordinated by various biological factors. In immunocompromised states wound healing can be interrupted as a result of decreased numbers of immune cells, impairing the production of effector molecules such as nitric oxide (NO). Therefore, topical NO-releasing platforms, such as diethylenetriamine (DETA NONOate), have been investigated to enhance wound healing. Recently, we demonstrated a nanoparticle platform that releases NO (NO-NPs) in a sustained manner, accelerating wound healing in both uninfected and infected murine wound models. Here, NO-NPs were investigated and compared to DETA NONOate in an immunocompromised wound model using non-obese, diabetic, severe combined immunodeficiency mice. NO-NP treatment accelerated wound closure as compared to controls and DETA NONOate treatment. In addition, histological assessment revealed that wounds treated with NO-NPs had less inflammation, more collagen deposition, and more blood vessel formation as compared to other groups, consistent with our previous data in immunocompetent animals. These data suggest that NO-NPs may serve as a novel wound-healing therapy in the setting of immunocompromised states associated with impaired wound healing. FROM THE CLINICAL EDITOR Wound healing in an immunocompromised host is often incomplete and is a source of major concern in such conditions. This work demonstrates in a murine model that in these settings NO releasing nanoparticles significantly enhance wound healing.

[1]  U. Tantry,et al.  Nitric oxide in the healing wound: a time-course study. , 2001, The Journal of surgical research.

[2]  Timothy R Billiar,et al.  Impaired wound healing and angiogenesis in eNOS-deficient mice. , 1999, American journal of physiology. Heart and circulatory physiology.

[3]  M. Fujimoto,et al.  CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling. , 2009, The American journal of pathology.

[4]  U. Tantry,et al.  Inhibition of nitric oxide synthesis in wounds: pharmacology and effect on accumulation of collagen in wounds in mice. , 1999, The European journal of surgery = Acta chirurgica.

[5]  Tarynn M Witten,et al.  Impaired wound healing. , 2007, Clinics in dermatology.

[6]  Simon C Watkins,et al.  Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. , 1997, Journal of medicinal chemistry.

[7]  J. Friedman,et al.  Exogenous nitric oxide prevents cardiovascular collapse during hemorrhagic shock. , 2011, Resuscitation.

[8]  George Broughton,et al.  The Basic Science of Wound Healing , 2006, Plastic and reconstructive surgery.

[9]  T. Doetschman,et al.  Delayed Wound Healing in Immunodeficient TGF-β1 Knockout Mice , 2000 .

[10]  R. Shankar,et al.  Nitric oxide inhibits wound collagen synthesis , 1999, Molecular and Cellular Biochemistry.

[11]  T. Doetschman,et al.  Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. , 2000, The Journal of investigative dermatology.

[12]  Joel Friedman,et al.  New biomaterials for the sustained release of nitric oxide: past, present and future , 2009, Expert opinion on drug delivery.

[13]  R. Kirsner,et al.  State of the Art in Topical Wound-Healing Products , 2011, Plastic and reconstructive surgery.

[14]  A. Barbul,et al.  Lymphocyte participation in wound healing. Morphologic assessment using monoclonal antibodies. , 1987, Annals of surgery.

[15]  J. Friedman,et al.  Nitric oxide-releasing nanoparticles accelerate wound healing by promoting fibroblast migration and collagen deposition. , 2012, The American journal of pathology.

[16]  C. Wastell,et al.  Effect of CD4+ and CD8+ cell depletion on wound healing , 2001, The British journal of surgery.

[17]  R. Weller,et al.  The effects of topical treatment with acidified nitrite on wound healing in normal and diabetic mice. , 2006, Nitric oxide : biology and chemistry.

[18]  M. V. von Herrath,et al.  Mouse Models for Type 1 Diabetes. , 2009, Drug discovery today. Disease models.

[19]  R. Weller,et al.  Nitric oxide: a key mediator in cutaneous physiology , 2003, Clinical and experimental dermatology.

[20]  U. Tantry,et al.  Nitric oxide regulates wound healing. , 1996, The Journal of surgical research.

[21]  Tadeusz Malinski,et al.  Role of nitric oxide, nitroxidative and oxidative stress in wound healing. , 2005, Pharmacological reports : PR.

[22]  Adam J Friedman,et al.  Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. , 2009, The Journal of investigative dermatology.

[23]  R. Shankar,et al.  Nitric oxide inhibits wounds collagen synthesis. , 1999, Molecular and cellular biochemistry.

[24]  P. Efron,et al.  Diabetes-impaired healing and reduced wound nitric oxide synthesis: a possible pathophysiologic correlation. , 1997, Surgery.

[25]  A. Barbul,et al.  The Effect of In Vivo T Helper and T Suppressor Lymphocyte Depletion on Wound Healing , 1989, Annals of surgery.

[26]  S. Levenson,et al.  Effect of the inflammatory reaction on subsequent wound healing. , 1966, Surgical forum.

[27]  D. Smith,et al.  Enhancement of wound repair with a topically applied nitric oxide‐releasing polymer , 1996, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[28]  J. Friedman,et al.  Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. , 2008, Nitric oxide : biology and chemistry.

[29]  D. Smith,et al.  Evaluation of linear polyethyleneimine/nitric oxide adduct on wound repair: therapy versus toxicity , 1998, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[30]  D. Steed,et al.  Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. , 1998, The Journal of clinical investigation.

[31]  S. Wahl,et al.  Lymphocyte-mediated activation of fibroblast proliferation and collagen production. , 1978, Journal of immunology.

[32]  A. Singer,et al.  Cutaneous wound healing. , 1999, The New England journal of medicine.

[33]  G. Garcı́a-Cardeña,et al.  Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.

[34]  M. Eisenberg,et al.  A novel model of wound healing in the SCID mouse using a cultured human skin substitute , 2009, The Australasian journal of dermatology.

[35]  J. Friedman,et al.  Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide. , 2011, American journal of physiology. Heart and circulatory physiology.

[36]  J. Friedman,et al.  Nitric oxide releasing nanoparticle synthesis and characterization. , 2011, Methods in molecular biology.

[37]  Teresa Pereira,et al.  Stabilization of HIF-1α is critical to improve wound healing in diabetic mice , 2008, Proceedings of the National Academy of Sciences.

[38]  P. Rabinovitch,et al.  Regulation of growth of human diploid fibrobalasts by factors elaborated by activated lymphoid cells , 1982, Journal of cellular physiology.